Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.5 GBX | +1.39% | 0.00% | -20.65% |
May. 15 | Creo Medical on track to break even next year on strong 2023 results | AN |
May. 15 | Creo Medical Group PLC Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2023 | 30.8M 39.18M | Sales 2024 * | 39.62M 50.4M | Capitalization | 127M 162M |
---|---|---|---|---|---|
Net income 2023 | -21M -26.71M | Net income 2024 * | -13M -16.54M | EV / Sales 2023 | 5.2 x |
Net cash position 2023 * | 22.03M 28.02M | Net cash position 2024 * | 132K 168K | EV / Sales 2024 * | 3.21 x |
P/E ratio 2023 |
-6.57
x | P/E ratio 2024 * |
-9.71
x | Employees | 279 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 79.14% |
1 day | +1.39% | ||
1 month | +5.04% | ||
3 months | -1.35% | ||
6 months | +8.15% | ||
Current year | -20.65% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | - | |
Craig Gulliford
CEO | Chief Executive Officer | - | 11-12-31 |
President | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Charles Spicer
CHM | Chairman | 59 | 16-06-30 |
John Bradshaw
BRD | Director/Board Member | 60 | - |
Craig Gulliford
CEO | Chief Executive Officer | - | 11-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 36.5 | +1.39% | 336,335 |
24-06-06 | 36 | 0.00% | 288,247 |
24-06-05 | 36 | 0.00% | 301,280 |
24-06-04 | 36 | -1.37% | 1,586,146 |
24-06-03 | 36.5 | 0.00% | 171,648 |
Delayed Quote London S.E., June 07, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.65% | 160M | |
-24.88% | 7.61B | |
+7.04% | 6.63B | |
+15.10% | 5.53B | |
-15.87% | 4.89B | |
+14.96% | 4.17B | |
-21.75% | 3.99B | |
-25.03% | 2.88B | |
+44.01% | 2.38B | |
+1.98% | 2.08B |
- Stock Market
- Equities
- CREO Stock